2-Bromo-Isovanillin Anticancer Activity and Sensitization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for malignant tumors lack effective preventive and therapeutic agents, and vanillin derivatives have shown limited anticancer activity compared to 2-bromo-isovanillin in inhibiting cancer cell proliferation and sensitizing cells to radiation and chemotherapy.
Innovation Solution
2-bromo-isovanillin, a derivative of vanillin, is used in the preparation of anticancer and radio- and chemotherapy sensitizing medicaments, administered in forms such as capsules, tablets, powders, or injections, to inhibit cancer cell proliferation, induce apoptosis, and increase sensitivity to treatments, with a broad-spectrum activity against various human cancers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional vanillin derivatives are used for anticancer treatment, then the treatment can be administered, but the anticancer activity is limited and insufficient to effectively inhibit cancer cell proliferation
Solution Approach 1:
The patent modifies the chemical structure of vanillin derivatives by introducing a bromine atom at the 2-position of the isovanillin molecule, creating 2-bromo-isovanillin. This structural parameter change significantly enhances the anticancer activity and ability to inhibit cancer cell proliferation compared to conventional vanillin derivatives, as demonstrated by the compound's superior inhibitory effect on various cancer cell lines.
2Reliability
If 2-bromo-isovanillin is used to enhance anticancer activity, then cancer cell proliferation is significantly inhibited, but the complexity of the compound structure increases
Solution Approach 1:
The patent introduces a single bromine atom at the 2-position of the isovanillin molecule, which is a minimal structural modification that significantly enhances anticancer activity without creating complex molecular structures. The modified structure remains relatively simple while achieving superior biological activity.
3Adaptability or versatility
If vanillin derivatives are used for chemotherapy sensitization, then the treatment can be combined with other therapies, but the sensitizing effect is insufficient compared to 2-bromo-isovanillin
Solution Approach 1:
The patent modifies the chemical structure of vanillin derivatives by introducing a bromine atom, which significantly enhances the compound's ability to sensitize cancer cells to chemotherapy and radiation. The modified structure demonstrates superior sensitizing effects compared to conventional vanillin derivatives, improving the reliability of combined therapy approaches.
Data Source
AI summary
Use of 2-bromo-isovanillin in the preparation of an anticancer medicament and/or radio- and chemotherapy sensitizing medicament is disclosed. The medicament for the treatment of cancers and/or for radio- and chemotherapy sensitization comprising 2-bromo-isovanillin as active ingredient provided herein has the following features: (1) low toxicity, without evident adverse effects; (2) significant therapeutic effect, with remarkable proliferation inhibiting and pro-apoptotic effects in tumor cells; (3) a broad-spectrum anticancer activity; (4) suitable to be used in combination with antimetabolites, to enhance the effects and meanwhile lower the toxicity, and also to reduce multi-drug resistance; (5) convenient and safe administration, the main route being oral.